Keratin ELISA Normalization for Cervical Cancer Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Immunological tests face challenges in standardizing and ensuring the presence of specific cells in samples, particularly from mucosa biopsies, due to variable expression of proteins and the presence of biomarkers in different cell types, making it difficult to obtain comparable results across samples.
Innovation Solution
A method involving a sandwich ELISA test for detecting keratin, combined with another biomarker test, to normalize and quantify the presence of cells in immunological samples, ensuring the presence of relevant cells for analysis, such as those infected with human papillomavirus (HPV), using antibodies specific to keratins 5, 8, and 18 for cervical cancer screening.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a single biomarker test is performed to detect the presence of specific cells, then the test simplicity is maintained, but the reliability of cell presence verification deteriorates due to variable protein expression and lack of normalization
Solution Approach 1:
The verification process is segmented into two independent tests: a normalization test detecting keratin (or other housekeeping protein) to verify cell presence and quantity, and a diagnostic test detecting the specific biomarker of interest. This segmentation allows each test to focus on its specific function, improving reliability while keeping individual test procedures simple and well-established.
Solution Approach 2:
A intermediary normalization step is introduced using a housekeeping protein (keratin, beta-actin, GAPDH, etc.) that serves as a reference marker. This intermediary provides a stable baseline against which the diagnostic biomarker results can be compared, enabling reliable verification of cell presence and adequate sampling without complicating the core diagnostic function.
2Measurement precision
If protein expression is used as the basis for cell detection, then immunological test methods are available, but measurement precision deteriorates due to variable expression levels depending on cell cycle, age, and pathologic changes
Solution Approach 1:
The approach changes the reference parameter from variable diagnostic biomarkers to stable housekeeping proteins (keratin, beta-actin, GAPDH, tubulin, lamin) that maintain consistent expression levels across different cell states. This parameter change provides a stable baseline for normalization, enabling precise measurement of cell presence and quantity regardless of cell cycle stage, age, or pathologic changes.
Solution Approach 2:
The housekeeping protein detection provides feedback information about the actual cell content and quality of the sample. This feedback is used to normalize the diagnostic biomarker results, allowing adjustment for variations in cell number and sampling adequacy, thereby improving measurement precision through comparative analysis.
3Measurement precision
If samples are obtained from mucosa without verification, then the sampling process is simple, but the accuracy of diagnostic results deteriorates due to insufficient or non-representative cell numbers
Solution Approach 1:
A preliminary verification step is performed using housekeeping protein detection to confirm adequate cell presence and sampling quality before proceeding with diagnostic interpretation. This preliminary action ensures that subsequent diagnostic results are based on sufficient and representative cell numbers, improving accuracy without significantly complicating the overall workflow.
Solution Approach 2:
An intermediary normalization marker (housekeeping protein) is introduced to mediate between the simple sampling process and the diagnostic interpretation. This intermediary provides objective verification of sampling adequacy, bridging the gap between ease of sample collection and accuracy of diagnostic results by confirming sufficient cell presence.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides reliable normalization and semi-quantitative analysis, ensuring that samples contain sufficient relevant cells, enhancing the accuracy of HPV detection and cervical cancer screening by standardizing the sampling process.
Implementation Method 1
One test is a sandwich ELISA test wherein the presence or absence of keratin is determined
Implementation Method 2
One test is a sandwich ELISA test wherein the presence or absence of keratin is determined and potentially quantitatively measured
Data Source
AI summary
Herein disclosed is a method for the normalization of an immunological test, characterized in that the presence of a comparable amount of cells is determined by a sandwich ELISA test in which the capture antibody includes at least one antibody that binds to at least one keratin selected from among keratin 4, 5, 6, 8, 10, 13 and 18 and the detection antibody includes at least one antibody that binds to the selected keratin.